We Can Medicines , Ltd. Long Term Debt

We Can Medicines , Ltd. (6929.TWO) currently reports a long-term debt of $860M as of June 2026. That compares with $1B in the prior-year period — down 14.1% year over year. Use the charts on this page to explore We Can Medicines , Ltd.'s long-term debt history and peer comparisons.

We Can Medicines , Ltd.'s long-term debt decreased from $1B to $860M — a 14.1% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

We Can Medicines , Ltd. reported $860M in long-term debt as of June 2026. That compares with $1B in the prior-year period — down 14.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current long-term debt of $860M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for We Can Medicines , Ltd., and consider following 6929.TWO for alerts when major investors trade the stock.